Versalovic J et al. |
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301997
|
Hoffman JS |
Pharmacological therapy of Helicobacter pylori infection. |
1997 |
Semin. Gastrointest. Dis. |
pmid:9232728
|
Sano M et al. |
[A clinical study on combination therapy of antimicrobial agents for complicated urinary tract infection--with special reference to combination with clarithromycin]. |
1997 |
Nippon Hinyokika Gakkai Zasshi |
pmid:9234616
|
Saluja A et al. |
A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. |
1997 |
Dermatol Surg |
pmid:9236871
|
Gisbert JP et al. |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. |
1997 |
Med Clin (Barc) |
pmid:9190436
|
Damianos AJ and McGarrity TJ |
Treatment strategies for Helicobacter pylori infection. |
1997 |
Am Fam Physician |
pmid:9191460
|
Ebell MH et al. |
Evaluation of the dyspeptic patient: a cost-utility study. |
1997 |
J Fam Pract |
pmid:9191627
|
Griffith DE |
Nontuberculous mycobacteria. |
1997 |
Curr Opin Pulm Med |
pmid:9193860
|
Villanueva A et al. |
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. |
1997 |
Clin. Infect. Dis. |
pmid:9195073
|
Woo MS et al. |
Pediatric transplant grand rounds. A case presentation: skin lesions in a post-lung transplant patient. |
1997 |
Pediatr Transplant |
pmid:10084776
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Reed PI and Johnston BJ |
Treatment of Helicobacter pylori infection. |
1997 |
Biomed. Pharmacother. |
pmid:9084725
|
Plemmons RM et al. |
Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. |
1997 |
Clin. Infect. Dis. |
pmid:9142810
|
Khan AA et al. |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145840
|
Collins L and Franzblau SG |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145860
|
Lounis N et al. |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145892
|
Spinzi G et al. |
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9146769
|
Peterson WL |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9146787
|
Pendland SL et al. |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. |
1997 |
J. Clin. Microbiol. |
pmid:9350781
|
Banerjee DK et al. |
Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9021187
|
Paar D et al. |
Life-threatening interaction between clarithromycin and disopyramide. |
1997 |
Lancet |
pmid:9024381
|
Wang XM et al. |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy]. |
1997 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:9028149
|
MacÃas J et al. |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. |
1997 |
AIDS |
pmid:9030376
|
Rodrigues AD and Wong SL |
Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience. |
1997 |
Adv. Pharmacol. |
pmid:9342173
|
Yasui N et al. |
Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients. |
1997 |
Int Clin Psychopharmacol |
pmid:9347384
|
May T et al. |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida. |
1997 |
Clin. Infect. Dis. |
pmid:9314450
|
Wright DH |
Regression of mucosa-associated lymphoid-tissue lymphoma after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:9314895
|
Picardeau M et al. |
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia. |
1997 |
J. Clin. Microbiol. |
pmid:9316897
|
Chey WD et al. |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. |
1997 |
Am. J. Gastroenterol. |
pmid:9317068
|
Pipkin GA et al. |
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review. |
1997 |
Helicobacter |
pmid:9421117
|
Tompkins DS et al. |
Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. |
1997 |
Helicobacter |
pmid:9421121
|
Taylor JL et al. |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. |
1997 |
Arch. Intern. Med. |
pmid:8996045
|
|
Drugs for treatment of peptic ulcers. |
1997 |
Med Lett Drugs Ther |
pmid:8996458
|
Stone GG et al. |
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9056021
|
Moayyedi P et al. |
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. |
1997 |
J. Gastroenterol. |
pmid:9058291
|
Dautzenberg B |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. |
1997 |
Drugs |
pmid:9358194
|
Reisner BS et al. |
Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin. |
1997 |
Int. J. Tuberc. Lung Dis. |
pmid:9432376
|
Lerang F et al. |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. |
1997 |
Scand. J. Gastroenterol. |
pmid:9438318
|
Akiyama H et al. |
Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. |
1997 |
J. Dermatol. Sci. |
pmid:9438901
|
Bazzoli F and Pozzato P |
Therapy of H. pylori infection. |
1997 |
J. Physiol. Pharmacol. |
pmid:9440054
|
Dixon JS et al. |
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori. |
1997 |
J. Physiol. Pharmacol. |
pmid:9440055
|
Yatsunami J et al. |
Clarithromycin is a potent inhibitor of tumor-induced angiogenesis. |
1997 |
Res Exp Med (Berl) |
pmid:9440137
|
Konishi T and Nakao M |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. |
1997 |
Microbiol. Immunol. |
pmid:9087959
|
GarcÃa-de-Lomas J et al. |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063666
|
Weiss I et al. |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063669
|
Price J and Hamilton W |
Pragmatic eradication of H. pylori. |
1997 |
Br J Gen Pract |
pmid:9474836
|
Feldman C et al. |
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. |
1997 |
Inflammation |
pmid:9429912
|
Misiewicz JJ |
Management of Helicobacter pylori-related disorders. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9160212
|
Williams MP et al. |
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9305479
|
Hultén K et al. |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371366
|
Sánchez-Nuñez ML et al. |
Clarithromycin in the treatment of cyclosporin-associated gingival hyperplasia. |
1997 |
Nephrol. Dial. Transplant. |
pmid:9306384
|
Finkenbine R and Gill HS |
Case of mania due to prednisone-clarithromycin interaction. |
1997 |
Can J Psychiatry |
pmid:9307841
|
Gisbert JP et al. |
Unhealed duodenal ulcers despite Helicobacter pylori eradication. |
1997 |
Scand. J. Gastroenterol. |
pmid:9246702
|
Barry AL et al. |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9405952
|
Fuursted K |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method. |
1997 |
J. Antimicrob. Chemother. |
pmid:9249202
|
Polis MA et al. |
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257746
|
Shibata K et al. |
Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori. |
1997 |
Jpn J Antibiot |
pmid:9258741
|
Böttger EC et al. |
Prophylaxis of mycobacterial infection and acquired drug resistance. |
1997 |
J. Antimicrob. Chemother. |
pmid:9249224
|
Sato K et al. |
[Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages]. |
1997 |
Kekkaku |
pmid:9259129
|
Peloquin CA and Berning SE |
Advice on treatment of Mycobacterium avium complex infection. |
1997 |
Am J Health Syst Pharm |
pmid:9161632
|
OÄŸuz O et al. |
Conjunctival involvement in familial chronic benign pemphigus (Hailey-Hailey disease). |
1997 |
Int. J. Dermatol. |
pmid:9169328
|
Mitsuyama T et al. |
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9338603
|
Alfandari S et al. |
Isolated cutaneous Mycobacterium avium complex infection in AIDS. |
1997 |
Int. J. Dermatol. |
pmid:9169332
|
Walsh D et al. |
One week treatment for Helicobacter pylori infection. |
1997 |
Arch. Dis. Child. |
pmid:9166031
|
Suzuki Y et al. |
[Antimicrobial activities of clarithromycin against recent obtained clinical isolates]. |
1997 |
Jpn J Antibiot |
pmid:9394238
|
Midolo PD et al. |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. |
1997 |
Pathology |
pmid:9423225
|
Phull PS et al. |
Lansoprazole plus clarithromycin: evaluation of a new dual therapy for Helicobacter pylori eradication. |
1996 Oct-Nov |
Br J Clin Pract |
pmid:9015906
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Prescott LM |
Clarithromycin for MAC prevention offers additional benefits. |
1996 May-Jun |
Posit Aware |
pmid:11363431
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Ono T et al. |
In vitro and in vivo antibacterial activities of clarithromycin. |
1996 May-Jun |
Chemotherapy |
pmid:8983882
|
Nightingale SL |
From the Food and Drug Administration. |
1996 May 22-29 |
JAMA |
pmid:8622234
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Akamatsu H et al. |
Enhanced effect of clarithromycin on neutrophil function in vitro. |
1996 Mar-Apr |
J. Int. Med. Res. |
pmid:8737228
|
Papp J et al. |
Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report. |
1996 Jul-Aug |
Br J Clin Pract |
pmid:8794601
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Sander P et al. |
Ribosomal drug resistance in mycobacteria. |
1996 Jan-Feb |
Res. Microbiol. |
pmid:8761724
|
Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Berg-Candolfi M and Candolfi E |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection. |
1996 |
Int. J. Parasitol. |
pmid:9024879
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
Matsuoka N et al. |
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. |
1996 |
Clin. Exp. Immunol. |
pmid:9099936
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Dammann HG |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis. |
1996 |
Dig. Dis. Sci. |
pmid:8617126
|
Kondoh K et al. |
Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. |
1996 |
Acta Otolaryngol Suppl |
pmid:8908271
|
Moreno JA et al. |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. |
1996 |
J. Gastroenterol. |
pmid:8959519
|
Satoh K et al. |
Efficacy of clarithromycin in eradicating Helicobacter pylori. |
1996 |
J. Gastroenterol. |
pmid:8959520
|
Shimoyama T et al. |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients. |
1996 |
J. Gastroenterol. |
pmid:8959522
|
Chen S et al. |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592303
|
Liu W et al. |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592304
|
Webb DD |
Practice guidelines for treatment of peptic ulcer disease. |
1996 |
JAMA |
pmid:8827959
|
Erah PO et al. |
Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832427
|
Vangala R and Cernek PK |
Hypersensitivity reaction to clarithromycin. |
1996 |
Ann Pharmacother |
pmid:8833572
|
Riff DS et al. |
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398874
|
Harford W et al. |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. |
1996 |
Helicobacter |
pmid:9398875
|
Schwartz H et al. |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398876
|
Barry AL et al. |
Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722555
|
|
H. pylori treatment recognized by FDA. |
1996 |
Am J Health Syst Pharm |
pmid:8725200
|